An Economic Analysis of Transjugular Intrahepatic Portosystemic Covered Stent Shunt for Variceal Bleeding and Refractory Ascites in a Spanish Setting

被引:3
作者
Banares, Rafael [1 ,2 ,3 ]
Albillos, Agustin [3 ,4 ]
Nakum, Mitesh [5 ]
Gea, Salvador [6 ]
Varghese, Angel [7 ]
Green, William [7 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Serv Med Aparato Digest, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
[2] Univ Complutense Madrid, Madrid, Spain
[3] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
[4] Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, Inst Ramon y Cajal Invest Sanitaria IRYCIS, Madrid, Spain
[5] WL Gore & Associates Ltd, Newark, NJ USA
[6] Gore & Asociados SL, Barcelona, Spain
[7] Univ York, York Hlth Econ Consortium Ltd, Enterprise House,Innovat Way, York YO10 5NQ, England
关键词
Variceal bleeding; Ascites; Cirrhosis; TIPSS; Endoscopic band ligation; Large volume paracentesis; Spain; Cost-utility; QALY; QUALITY-OF-LIFE; COST-EFFECTIVENESS; ESOPHAGEAL-VARICES; FREE SURVIVAL; TIPS; CIRRHOSIS; METAANALYSIS; PREVENTION;
D O I
10.1007/s12325-023-02517-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
IntroductionThe primary aim is to estimate the cost-effectiveness of transjugular intrahepatic portosystemic stent shunt (TIPSS) in two indications from a Spanish perspective. Firstly, as pre-emptive treatment for patients with acute variceal bleeding (indication 1) compared with endoscopic band ligation plus drug therapy. Secondly, to treat refractory ascites (indication 2) compared with large volume paracentesis.MethodsA two-state (alive and dead) Markov model was developed to capture the costs and health impact for the two indications over a 2-year time horizon with monthly cycles. In the alive state, patients could experience adverse event(s), associated with costs and disutility, such as recurrent variceal bleeding, ascites, and hepatic encephalopathy. Discount rates of 3% for utilities and costs and a cost-effectiveness threshold of euro25,000 per QALY were applied.ResultsIn the base case analysis, TIPSS was estimated to be cost-effective as a pre-emptive treatment for indication 1 (incremental cost and QALYs of - euro230 and 0.211, respectively). TIPSS also remained cost-effective (euro16,819/QALY) in a conservative scenario analysis, conducted with an alternate source for clinical parameters. The key drivers of the outcomes were survival for the comparator arm, mean band ligation outpatient procedures, and TIPSS treatment costs. TIPSS was estimated to dominate the comparator for indication 2 (incremental cost and QALYs of - euro25,687 and 0.531, respectively). The key drivers of the outcomes were monthly paracentesis sessions and cost per inpatient stay for those undergoing paracentesis.ConclusionsTIPSS is likely to be a cost-effective and a cost-saving treatment in patients with cirrhosis in indications 1 and 2, compared with standard treatments. The analyses estimate clinical benefits along with reduced healthcare costs from avoided downstream resource consumption.
引用
收藏
页码:3006 / 3020
页数:15
相关论文
共 50 条
[21]   Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications [J].
Will, Valerie ;
Rodrigues, Susana G. ;
Stirnimann, Guido ;
De Gottardi, Andrea ;
Bosch, Jaime ;
Berzigotti, Annalisa .
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (08) :961-969
[22]   Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites [J].
Williams, DB ;
Waugh, R ;
Selby, W .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1998, 28 (05) :620-626
[23]   Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: A systematic review with meta-analysis [J].
Weichselbaum, Laura ;
Lepida, Antonia ;
Marot, Astrid ;
Trepo, Eric ;
Moreno, Christophe ;
Deltenre, Pierre .
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2022, 10 (08) :874-887
[24]   The Role of Transjugular Intrahepatic Portosystemic Shunt for the Management of Ascites in Patients with Decompensated Cirrhosis [J].
Iannone, Giulia ;
Pompili, Enrico ;
De Venuto, Clara ;
Pratelli, Dario ;
Tedesco, Greta ;
Baldassarre, Maurizio ;
Caraceni, Paolo ;
Zaccherini, Giacomo .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
[25]   Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience [J].
Lodato, Francesca ;
Berzigotti, Annalisa ;
Lisotti, Andrea ;
Azzaroli, Francesco ;
Mosconi, Cristina ;
Giampalma, Emanuela ;
Renzulli, Matteo ;
Cappelli, Alberta ;
Buonfiglioli, Federica ;
Calvanese, Claudio ;
Zoli, Marco ;
Golfieri, Rita ;
Mazzella, Giuseppe .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (12) :1494-1500
[26]   Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis [J].
Deltenre, P ;
Mathurin, P ;
Dharancy, S ;
Moreau, R ;
Bulois, P ;
Henrion, J ;
Pruvot, FR ;
Ernst, O ;
Paris, JC ;
Lebrec, D .
LIVER INTERNATIONAL, 2005, 25 (02) :349-356
[27]   Emergency transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding [J].
Abujudeh, H. ;
Parikh, D. ;
Baker, S. .
EMERGENCY RADIOLOGY, 2005, 11 (03) :183-185
[28]   Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding [J].
Njei, Basile ;
McCarty, Thomas R. ;
Laine, Loren .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) :852-858
[29]   Transjugular intrahepatic portosystemic shunt for the refractory ascites: retrospective korean multicenter data [J].
Kim, H. K. ;
Kim, Y. S. ;
Jung, Y. K. ;
Chung, W. J. ;
Woo, H. Y. ;
Park, S. J. ;
Kim, D. Y. ;
Shim, J. J. ;
Park, S. Y. ;
Lee, J. M. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 :846-846
[30]   Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis [J].
Azoulay, D ;
Castaing, D ;
Majno, P ;
Saliba, F ;
Ichaï, P ;
Smail, A ;
Delvart, V ;
Danaoui, M ;
Samuel, D ;
Bismuth, H .
JOURNAL OF HEPATOLOGY, 2001, 35 (05) :590-597